Articles with public access mandates - paola reboraLearn more
Not available: 6
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis
G D’Amico, A Morabito, M D’Amico, L Pasta, G Malizia, P Rebora, ...
Hepatology international 12 (1), 34-43, 2018
Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
S Genovesi, P Rebora, M Gallieni, A Stella, F Badiali, F Conte, S Pasquali, ...
Journal of nephrology 30 (4), 573-581, 2017
Indicators based on registers and administrative data for breast cancer: routine evaluation of oncologic care pathway can be implemented
A Andreano, E Anghinoni, M Autelitano, A Bellini, M Bersani, S Bizzoco, ...
Journal of evaluation in clinical practice 22 (1), 62-70, 2016
A unified model for estimating and testing familial aggregation
M Lee, P Rebora, MG Valsecchi, K Czene, M Reilly
Statistics in medicine 32 (30), 5353-5365, 2013
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study
A Talvik, P Rebora, M Heinpalu-Kuum, S Salerno, ...
Blood pressure 27 (6), 368-375, 2018
Available: 12
Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes
S Corbetta, F Raimondo, S Tedeschi, ML Syrèn, P Rebora, A Savoia, ...
Nephrology Dialysis Transplantation 30 (4), 621-630, 2015
Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk
F Viazzi, P Rebora, M Giussani, A Orlando, A Stella, L Antolini, ...
Hypertension 67 (5), 934-940, 2016
Outcome of children with hypodiploid acute lymphoblastic leukemia: a retrospective multinational study
CH Pui, P Rebora, M Schrappe, A Attarbaschi, A Baruchel, G Basso, ...
Journal of Clinical Oncology 37 (10), 770, 2019
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
R Franca, P Rebora, N Bertorello, F Fagioli, V Conter, A Biondi, ...
The pharmacogenomics journal 17 (1), 4-10, 2017
Low PKCa expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome
G Milani, P Rebora, B Accordi, L Galla, S Bresolin, G Cazzaniga, B Buldini, ...
Oncotarget 5 (14), 5234, 2014
Patterns of changing cancer risks with time since diagnosis of a sibling
M Lee, K Czene, P Rebora, M Reilly
International journal of cancer 136 (8), 1948-1956, 2015
High risks of familial chronic lymphatic leukemia for specific relatives: signposts for genetic discovery?
P Rebora, M Lee, K Czene, MG Valsecchi, M Reilly
Leukemia 26 (11), 2419-2421, 2012
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach
A Andreano, P Rebora, MG Valsecchi, AG Russo
Breast cancer research and treatment 164 (1), 119-131, 2017
Pulse wave velocity progression over a medium‐term follow‐up in hypertensives: Focus on uric acid
A Maloberti, P Rebora, A Andreano, P Vallerio, B De Chiara, S Signorini, ...
The Journal of Clinical Hypertension 21 (7), 975-983, 2019
Crude incidence in two-phase designs in the presence of competing risks
P Rebora, L Antolini, DV Glidden, MG Valsecchi
BMC medical research methodology 16 (1), 1-16, 2016
Self-care in People with Type 2 Diabetes Mellitus–Research Protocol of a Multicenter Mixed Methods Study (SCUDO)
M Luciani, D Fabrizi, P Rebora, E Rossi, S Di Mauro, SK Malone, D Ausili
Professioni infermieristiche 72 (3), 203, 2019
Oxygenation derangements after subarachnoid hemorrhage: incidence and impact on the outcome. Data from a large multicenter, retrospective study.
A Mazeraud, C Robba, C Iaquaniello, P Rebora, A Vargiolu, V Rass, ...
Publication and funding information is determined automatically by a computer program